EUVIMEDEUVIMED entdecken
Open Access

Primordial Follicle Survival and Changes in Ovarian Vasculature May Be Independently Regulated During Chemotherapy

Wonmi So iD, Rosemary Dong, Donghee Lee, Amirhossein Abazarikia, Bryan T Hackfort, Andrea S Cupp, So-Youn Kim iD

Endocrinology · 2025

DOI: 10.1210/endocr/bqaf059 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrinology, 2025. Verfasst von Wonmi So und 6 weiteren Autor:innen. Beteiligte Einrichtung: Olson Center for Women's Health, Department of Obstetrics and Gynecology, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA. Hauptthemen laut MEDLINE: Ovarian Follicle, Ovary, Antineoplastic Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Nebraska Center for Nanomedicine (NCN) at UNMC, NICHD NIH HHS, NRI Collaboration Initiative.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemotherapeutic agents induce irreversible gonadotoxic side effects, resulting in endocrine dysfunction and infertility in female cancer survivors. In the current study, we investigated strategies to protect ovarian function from chemotherapy-induced toxicity by evaluating the effects of cisplatin, doxorubicin, or cyclophosphamide on ovarian vasculature and primordial follicle survival. This investigation was conducted using adult CD-1, PDs 5-7 CD-1, and oocyte-specific Trp63 conditional knockout (Trp63 cKO) mice that demonstrated primordial follicles survived following chemotherapy. In control ovaries, vasculature typically surrounds primordial and primary follicles, is in the theca layer as secondary follicles develop, and is distributed among stromal cells. Our findings revealed that the expression pattern of CD31/PECAM-1 (platelet endothelial adhesion molecule-1) was significantly altered in ovaries treated with chemotherapeutic agents compared with controls. The data demonstrate that these agents not only caused the loss of ovarian follicles but also damaged the ovarian vasculature. Using Trp63 cKO mice and CK2II, an inhibitor of checkpoint kinase 2, we demonstrated that vascular damage can occur independently of primordial follicle loss, and VEGFA165 was unable to prevent either outcome. This indicates that the mechanisms governing the death of primordial follicles and vascular damage may not directly affect each other. Long-term ex vivo culture and in vivo experiments demonstrated the ability of ovarian vasculature to recover from cisplatin-induced damage. In conclusion, our study suggests that ovarian follicle survival and vascular integrity may be independently regulated as independent processes, governed by distinct signaling pathway or mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian FollicleOvaryAntineoplastic AgentsAnimalsFemaleMiceMice, KnockoutCisplatinCyclophosphamideDoxorubicinVascular Endothelial Growth Factor APlatelet Endothelial Cell Adhesion Molecule-1

Stichwörter der Autor:innen

CD31ovarian vasculatureovaryprimordial follicles

Substanzen

CisplatinCyclophosphamideAntineoplastic AgentsDoxorubicinVascular Endothelial Growth Factor APlatelet Endothelial Cell Adhesion Molecule-1

Autor:innen und Institutionen

  • Olson Center for Women's Health, Department of Obstetrics and Gynecology, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
  • Department of Surgery-Transplant and Mary & Dick Holland Regenerative Medicine Program, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
  • Department of Cellular and Integrative Physiology, College of Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA.
  • Center for Heart and Vascular Research, University of Nebraska Medical Center, Omaha, NE 68198, USA.
  • Department of Animal Science, University of Nebraska-Lincoln, Lincoln, NE 68588, USA.
  • Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE 68198, USA.

ORCID-Profile: Wonmi So, So-Youn Kim

Förderung

  • Nebraska Center for Nanomedicine (NCN) at UNMC
  • NICHD NIH HHS
  • NRI Collaboration Initiative
  • NIGMS NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

So, W., Dong, R., Lee, D., Abazarikia, A., Hackfort, B. T., Cupp, A. S., & Kim, S. Y. (2025). Primordial Follicle Survival and Changes in Ovarian Vasculature May Be Independently Regulated During Chemotherapy. Endocrinology. https://doi.org/10.1210/endocr/bqaf059

Vancouver

So W, Dong R, Lee D, Abazarikia A, Hackfort BT, Cupp AS, et al. Primordial Follicle Survival and Changes in Ovarian Vasculature May Be Independently Regulated During Chemotherapy. Endocrinology. 2025. doi:10.1210/endocr/bqaf059

BibTeX
@article{So2025,
  author = {So, Wonmi and Dong, Rosemary and Lee, Donghee and Abazarikia, Amirhossein and Hackfort, Bryan T and Cupp, Andrea S and Kim, So-Youn},
  title = {Primordial Follicle Survival and Changes in Ovarian Vasculature May Be Independently Regulated During Chemotherapy},
  journal = {Endocrinology},
  year = {2025},
  doi = {10.1210/endocr/bqaf059}
}
Kostenlos starten →